Cjepivo protiv pneumokoka, polisaharidno, konjugirano, adsorbirano, za imunizaciju dojenčadi, nabava za 2025. - 2027. godinu
HRVATSKI ZAVOD ZA JAVNO ZDRAVSTVO
Awarded to Pfizer Export B.V. for €1,743,750.
Interested in tenders like this? Get the next tenders like this one published in the European Union by email. Free, no card needed.
Amounts and figures
€13,003,878
Estimated value
1
Lots
5
Bids received
Description
Cjepivo protiv pneumokoka, polisaharidno, konjugirano, adsorbirano, za imunizaciju dojenčadi, nabava za 2025.-2027. godinu
Award criteria
| Type | Criterion | Weight |
|---|---|---|
| Price | Cijena ponude | — |
| Quality | Bodovi za broj serotipova pneumokoka sadržanih u cjepivu dodjeljuju se na slijedeći način: • 13 serotipova: 1 bod • 15 serotipova: 5 bodova • 20 serotipova: 18 bodova | — |
Awards
| Lot | Awarded to | Amount | Bids received | Date |
|---|---|---|---|---|
| LOT-0000 | Pfizer Export B.V. | €1,743,750 | 5 | 23 July 2025 |
Official publications
| Medium | Reference | Date |
|---|---|---|
| TED | 00577930-2025 | 4 September 2025 |
| OJS | 169/2025 | 4 September 2025 |
Other tenders from HRVATSKI ZAVOD ZA JAVNO ZDRAVSTVO
See the buyer →- Reagensi, testovi i ostali potrošni materijal za mirkobiologiju za zdravstvene ustanove u RH Published: 19 October 2026
- U275 - Analiza uzoraka biološkog materijala na zabranjene tvari iz međunarodnog Published: 5 October 2026
- Oprema i sredstva za čišćenje i održavanje za zdravstvene ustanove u RH Published: 5 October 2026
- Nadogradnja i migracija pojedinih grupa registara na NAJS IKTv2 podsustava na CDU Published: 25 September 2026
- Cjepivo protiv poliomijelitisa, inaktivirano, nabava za 2025-2027. godinu Published: 3 August 2026
- Cjepivo protiv meningokoka grupe B, nabava za 2025.-2027. godinu Published: 3 August 2026
- Imunoglobulin protiv bjesnoće ljudski Published: 3 August 2026
- Cjepivo protiv Herpes zostera iz Programa cijepljenja Published: 3 August 2026
- Cjepivo protiv pneumokoka, polisaharidno, nabava za 2025.-2027. godinu Published: 3 August 2026
- Cjepivo protiv pneumokoka, polisaharidno, konjugirano, adsorbirano, za imunizaciju dojenčadi, nabava za 2025. - 2027. godinu Published: 3 August 2026
Previous and next from HRVATSKI ZAVOD ZA JAVNO ZDRAVSTVO
- Cjepivo protiv difterije, tetanusa i pertusisa (acelularno), sa smanjenom količinom antigena za docijepljivanje u 4. r OŠ i 2 r. SŠ, nabava…
- Pribor i potrošni materijal za aparate Biorad
- Cjepivo protiv meningokoka grupe B, nabava za 2025.-2027. godinu
- Nabava fekalnog imunokemijskog testa (FIT) s uslugom pripreme i izrade tiskanog materijala, skladištenja i distribucije istog za provedbu…
- Cjepivo protiv Herpes zostera iz Programa cijepljenja
- Kombinirano cjepivo protiv difterije, tetanusa, pertusisa (acelularno), dječje paralize (inaktivirano), H. influenzae tipa B i hepatitisa B…
Similar open tenders
Frequently asked questions
- What is the estimated value of this tender?
- The estimated value published by the buyer is €13,003,878.
- Who is the buyer of this tender?
- The contracting authority is HRVATSKI ZAVOD ZA JAVNO ZDRAVSTVO (European Union).
- How can I bid for public tenders in the European Union?
- Bids are submitted through the official public procurement portal in the European Union. El Vínculo helps you find tenders and analyse their documents; submission always happens at the official source.
How can I find out about similar tenders when they are published?
Create an account at el-vinculo.com and we give you a free month and set up your company's filters — contract type, CPV codes, value and territory — so you are the first to know when new tenders like this one come out in the European Union. We email you as soon as one matching your profile is published, with the whole deadline ahead to prepare the bid.
Get alerts for tenders like this
Create a free account and receive new public tenders published in the European Union that match your business, every day.
Create a free account and receive new public tenders published in the European Union that match your business, every day.